Skip to main content
. 2020 Aug 26;21(17):6150. doi: 10.3390/ijms21176150
ACS Acute coronary syndrome
ADP Adenosine diphosphate
AEs Adverse events
AF Atrial fibrillation
ATP Adenosine triphosphate
C3 Complement 3
CAPs Carboxy(alkylpyrrole) protein adducts
CD62P P-selectin
cGMP Cyclic guanosine monophosphate
CVD Cardiovascular disease
DAMP Damage-associated molecular pattern
DAPT Dual anti-platelet therapy
FSL-1 Fibroblast stimulating lipopeptide-1
GP Glycoprotein
HCMV Human cytomegalovirus
HMGB1 High Mobility Group Box 1
IL Interleukin
LPS Lipopolysaccharide
MALP-2 Macrophage Activating Lipopeptide-2
MIP Macrophage inflammatory protein
MPO Myeloperoxidase
MPs Microparticles
mtDNA Mitochondrial DNA
NET Neutrophil extracellular trap
NF-κB Nuclear factor-kappa B
oxPC Oxidized phospholipids
PAMP Pathogen-associated molecular pattern
PBMCs Peripheral blood mononuclear cells
PC Platelet components
PF4 Platelet factor 4
PGSL-1 P-selectin glycoprotein ligand-1
PRP Platelet-rich plasma
PRR Pattern recognition receptor
RAGE Receptor for advanced glycation end products
RANTES Regulated upon Activation, Normal T cell Expressed and Secreted
sCD40L Soluble CD40L
TGF-β Transforming growth factor-β
TLRs Toll-like receptors
TNF-α Tumor necrosis factor-alpha
TRAP Thrombin receptor activator peptide
Treg Regulatory T cells
TxA2 Thromboxane A2
VAMP Vesicle-associated membrane protein
vWF Von Willebrand factor
WPs Washed platelets